Last reviewed · How we verify

NCT04627220

The Effect of Arterial Oxygen Parameters on Antioxidant Parameters

Completed Last updated 13 November 2020
What this trial tests

trial testing taken venous sample in Cardiovascular Diseases in 100 participants. Completed in 1 November 2020.

Timeline
1 January 2020
Primary endpoint
1 October 2020
1 November 2020

Quick facts

Lead sponsorBursa Yuksek Ihtisas Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 January 2020
Primary completion1 October 2020
Estimated completion1 November 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Who can join

Adults 18 to 75, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aimed to measure the changes in your blood values caused by different but safe oxygen values used by us during your heart surgery under laboratory conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Bursa Yuksek Ihtisas Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04627220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing